Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 7.51 | 0.66 | 9.72 |
| 6M | 4.83 | 1.60 | 8.52 |
| 1Y | 11.38 | 5.11 | 15.26 |
| 3Y | 23.97 | 14.01 | 113.97 |
Aditya Birla Sun Life Pharma & Healthcare Fund Growth managed by Aditya Birla Sun Life Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹901 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.3. Under the expert guidance of Dhaval Shah ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Dhaval Shah holds B.Com, CFA, MMS - Finance (Post graduation). He has worked with Morgan Stanley Investment Management, Reliance Capital Asset Management Ltd. and Edelweiss Securities.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| Nippon India Pharma Fund Growth | 4 | 8365.4 CR | 1.82 |
| Tata India Pharma & HealthCare Fund Growth | 2 | 1325.19 CR | 2.15 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Growth | 2 | 900.87 CR | 2.3 |
| UTI Healthcare Fund Growth | 3 | 1055.53 CR | 2.28 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 5 | 6668.95 CR | 1.87 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundNippon India Pharma Fund Growth | 8.2654 | 87.0192 |
| This FundTata India Pharma & HealthCare Fund Growth | 6.438 | 87.1141 |
| This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth | 11.3791 | 90.5288 |
| This FundUTI Healthcare Fund Growth | 11.4673 | 101.0945 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 9.8076 | 108.6846 |